We use third-party cookies to provide support. By continuing to browse this website,
you accept our privacy policy.
Summit Therapeutics Inc
2 own
6 watching
Current Price
$3.88
$0.08
(2.11%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Market Capitalization
781.13M
52-Week High
5.78
52-Week Low
0.66
Average Volume
3.56M
Dividend Yield
--
P/E Ratio
--
Market Capitalization781.13M52-Week High5.7852-Week Low0.66Average Volume3.56MDividend Yield--P/E Ratio--What does the Summit Therapeutics Inc do?
Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company s lead product candidate is ridinilazole, an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. It also offers SMT-738, for combating multidrug resistant infections primarily carbapenem-resistant Enterobacteriaceae infections; and DDS-04 series for the potential treatment of infections caused by the Enterobacteriaceae. The company was founded in 2003 and is based in Cambridge, Massachusetts.
Read More
How much money does Summit Therapeutics Inc make?
News & Events about Summit Therapeutics Inc.
Globe Newswire
11days ago
PHILADELPHIA, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Summit Therapeutics Inc. (NASDAQ: SMMT) (Summit) on behalf of the Companys investors. The investigation seeks to determine whether Summit issued false and misleading statements and/or failed to ...
Business Wire
14days ago
Summit Therapeutics Inc. (NASDAQ: SMMT) (Summit, we, or the Company) today announced that we have completed the closing of our previously announced definitive agreement with Akeso Inc. (HKEX Code: 9926.HK, Akeso) to in-license its breakthrough bispecific antibody, ivonescimab. Ivonescimab, known as...
Business Wire
29days ago
Summit Therapeutics Inc. (NASDAQ: SMMT) (Summit, we, or the Company) today announced that it will participate in and present at the 41st Annual J.P. Morgan Healthcare Conference on Monday, January 09, 2023, at 3:45 PM PST. Robert W. Duggan, Chairman and Chief Executive Officer, and Dr. Maky...
PR Newswire
1month ago
Thinking about buying stock in Baudax Bio, Zhihu, Vapotherm, Kingsoft Cloud, or Summit Therapeutics? Thinking about buying stock in Baudax Bio, Zhihu, Vapotherm, Kingsoft Cloud, or Summit Therapeutics? PR Newswire NEW YORK, Dec. 9, 2022 NEW YORK, Dec. 9, 2022 /PRNewswire/ -- InvestorsObserverissues...
PR Newswire
1month ago
Thinking about buying stock in Express, Carvana, Summit Therapeutics, AMC Entertainment, or Transocean? Thinking about buying stock in Express, Carvana, Summit Therapeutics, AMC Entertainment, or Transocean? PR Newswire NEW YORK, Dec. 8, 2022 NEW YORK, Dec. 8, 2022 /PRNewswire...
Frequently Asked Questions
Frequently Asked Questions
What is Summit Therapeutics Inc share price today?
Can Indians buy Summit Therapeutics Inc shares?
How can I buy Summit Therapeutics Inc shares from India?
Can Fractional shares of Summit Therapeutics Inc be purchased?
What are the documents required to start investing in Summit Therapeutics Inc stocks?
What is today’s traded volume of Summit Therapeutics Inc?
What is today’s market capitalisation of Summit Therapeutics Inc?
What is the 52-Week High and Low Range of Summit Therapeutics Inc?
What percentage is Summit Therapeutics Inc down from its 52-Week High?
What percentage is Summit Therapeutics Inc up from its 52-Week Low?
Current Price
$3.88
$0.08
(2.11%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.